comparemela.com

Page 6 - Sheetal Arora News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mankind Pharma s GMP Rises By Rs 100, Indicating Strong Listing Gains: Report

Mankind Pharma shares were in very high demand during the IPO as the share sale was subscribed 15.32 times subscribed by the last day of the offer

Rajeev junejaRamesh junejaSheetal aroraLink investmentKotak mahindra capital companyMankind pharmaInitial public offeringBeige limitedQualified institutional buyersRetail individual investorsMahindra capital companyAxis capitalJefferies indiaSwastika investmart

Mankind Pharma IPO Share Allotment: Check Direct Link To See Status, Today s GMP Other Details

Mankind Pharma will start refunds on May 4 if subscribers haven t already got the allotment.

New delhiRajeev junejaRamesh junejaSheetal aroraKotak mahindra capital companyLink investmentElin electronicsMankind pharmaBeige limitedLink investment trustMahindra capital companyAxis capitalJefferies indiaMankind pharma ipoMankind pharmaMankind pharma ipo share allotment

Mankind Pharma IPO: Check GMP, Listing Date And Other Details

Mankind Pharma will finalise the allocation of shares May 3, 2023.

New delhiSheetal aroraRamesh junejaRajeev junejaLink investmentKotak mahindra capital companyMankind pharmaBeige limitedLink investment trustMahindra capital companyAxis capitalJefferies indiaMankind pharma ipoMankind pharma ipo gmpMankind pharma

Mankind Pharma IPO GMP, Subscription, Review; Should You Buy on Last Day?

Mankind Pharma IPO: Today is the last day to apply for the public issue worth Rs 4,326.36 crore; Should you Buy?

Prashanth tapseRajeev junejaSheetal aroraRamesh junejaCanara bank securitiesLink investmentMankind pharma ltdMankind pharmaZydus lifeSenior vice presidentMehta equitiesChoice brokingLatest business newsTax newsStock market updatesMankind pharma ipo

Mankind Pharma IPO subscribed 2 times so far on final bidding day; QIB portion books about 6x

At the close of day two of bidding, the issue of Mankind Pharma was overall subscribed 87 per cent, with strong bidding from QIB and NII investors, whose quota sailed through.

Sheetal aroraRamesh junejaRajeev junejaSun pharmaKotak mahindra capital companyLink investmentMankind pharmaLink investment trustMahindra capital companyAxis capitalJefferies indiaFinancial yearMankind pharma ipoAnkind ipoMankind pharma price bandAnkind price band

vimarsana © 2020. All Rights Reserved.